Quarterly report pursuant to Section 13 or 15(d)

Note 1 - The Company and Summary of Significant Accounting Policies (Details)

v3.10.0.1
Note 1 - The Company and Summary of Significant Accounting Policies (Details) - shares
9 Months Ended
Sep. 30, 2018
Sep. 30, 2017
Anti-dilutive securities 2,977,958 1,514,905
Exercise of common stock warrants    
Anti-dilutive securities 1,813,053 0
Conversion of preferred stock into common stock    
Anti-dilutive securities 1,163,659 1,513,659
Exercise of common stock options    
Anti-dilutive securities 1,246 1,246